Home ›

Testing Center
Pharmacy Learning Network Chicago Conference - May 11-12, 2012
A WOC Nurse's Approach to Dressings
Pharmacy Learning Network Philadelphia Conference - March 30-31, 2012
Managing Wound Infections: Demystifying the Role of Topical Antimicrobials
Optimizing Multiple Myeloma Treatment and Supportive Care: Clinical and Cost Considerations for Managed Care
Advanced Stroke Care: Improved Efficiency Using Technology
Applying Available Data and Disease Management Programs to Optimize Gout Treatment and Outcomes
A Call to Action for Primary Care to Prevent Stroke in Atrial Fibrillation
Lead Extraction: Indications, Procedures, and Tools for Successful Laser-Free Extraction
Linking Evidence-Based Care to Improved Outcomes in Atrial Fibrillation: Evolving Pharmacologic Approaches
Advancing the RA Armamentarium with Emerging Therapies
Evolving Strategies to Improve Bone Health in Cancer Patients and Minimize the Burden of Skeletal-Related Events
Pharmacy Impact on Outcomes and Costs in the Surgical Suite: Focus on Optimal Hemostatic Practices
Optimizing Blood Utilization: Strategies for Improving Hemostatic Practices
Engaging the Patient with AF in Optimizing Care
Aggressively Pursuing Remission in RA: Where Will Emerging Therapies Fit into the Treatment Armamentarium?
Improving Outcomes in Major Depressive Disorder: Advancing Health Plan Performance and Community Health Using NCQA HEDIS® Measures
Case 3: HealthGuard Company is a commercial health plan that is conducting an annual review of agents used to treat multiple myeloma (MM). The most anticipated discussion surrounds MM therapy options and their impact on outcomes
Case 4: Lilly is a 38-year-old female with multiple myeloma (MM) who achieves a complete response after initial treatment. Nine months later, she relapses and requires treatment for refractory MM
The Future of the Cath Lab: Managing Complexity for Improved Safety and Outcomes in CTO, TAVI, and Carotid Intervention
Pursuing Type 2 Diabetes Treatment Goals among In-Plan Clinicians and Covered Patients: Payor Strategies for Optimizing Outcomes
Clinical and Scientific Aspects of Keratinocyte-Fibroblast Interaction in the Wound Healing Process
Clinical Applications of Amniotic Membranes in Chronic Wound Care
Managed Care Strategies for Diminishing the Burden of Dyslipidemia in Patients with Chronic Kidney Disease
The Development of Diagnostics in Wound Care: Proteases and Chronic Wound Healing; Moving Beyond Clinical Inertia
Advances in Ultrasound: Fly Thru & Smart Fusion Technology
Non-Contrast MR Imaging: CSF Flow and Multi-Phase Procedures
Evolving Treatment Landscape for AF-Related Stroke: Strategies to Optimize Anticoagulation and Resource Allocation
Facilitating Transradial PCI: From Access to X-Ray
Case 1: BeWell Company is a commercial health plan that is conducting an annual review of agents used to treat multiple myeloma (MM). The most anticipated discussion surrounds MM supportive treatments and their ability to improve care and lower costs.